CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SKYE

Nimacimab injection

Phase 2
Skye Bioscience, Inc. (SKYE)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '26
SKYEPhase 2

Nimacimab injection Phase 2 Est. Readout (CBeyond)

Nimacimab injection
Nov 2026~
CT.gov
00%
Drug Information

Target Indication

Obesity

Clinical Trial

NCT06577090

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMA6/27/2013

Maci

Repair of symptomatic cartilage defects of the knee.

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.